MONROVIA, Calif., Nov. 6, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the Stephens 2014 Fall Investment Conference at the New York Palace Hotel on Tuesday, November 11 at 12:00 p.m. PT/3:00 p.m. ET.

Barry Caldwell, President and CEO and Steve Brown, Chief Financial Officer will offer a general overview of the Company's current business trends, financial results, and operational developments in a fire side chat format which will include a question and answer period. A live audio-only webcast will be available from the Company's website, under Investor Information. An archived replay of management's presentation will be available for 90 days following the event, also at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 475,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.

SOURCE STAAR Surgical Company